MA-PRECISELY
Precisely, the global leader in data integrity, today announced that Devon and Cornwall Police leveraged its GIS software to enhance safety measures during the 2021 G7 Summit – the annual gathering of policy leaders from seven of the world’s major democracies. The local police force combined MapInfo Pro with third-party 3D visualizations to create a digital twin that enabled precise contingency planning – based on a model that had an accuracy of up to five millimeters.
The innovative use of geospatial solutions, alongside cutting-edge 3D technology, has huge implications for security and event planning. Mounting geopolitical tension is increasing the likelihood of security threats, meaning that high profile events, such as Queen Elizabeth II’s recent funeral procession, are requiring unprecedented levels of complex security protocol. The pandemic has also made contingency planning more challenging by limiting the ability to bring together large groups of people to do in-person planning.
“We had two major hurdles we had to cross during the planning phase for the G7 Summit,” said Robert Goldsmith, GIS and Mapping Manager, Devon and Cornwall Police. “The first challenge was managing the sheer volume of security protocols needed for such a high-profile event, particularly given that the Summit was hosted in two locations. This meant that safety measures were required for different venues, as well as for each of the world leaders, as they travelled back and forth. The second was giving visibility to our security partners around the world, especially as the pandemic limited the ability for teams to travel to the site in the run up to the event.”
The force’s GIS team quickly recognized that mapping software could play an important role to easily bring together data from a variety of sources and data formats, providing critical context in the assessment of all safety protocols leading up to and throughout the Summit. As an existing Precisely customer, Devon and Cornwall Police leveraged MapInfo Pro, a powerful desktop mapping solution that unlocks location-based context from data, empowering confident decisions grounded in visualizations of data patterns that would otherwise be hidden.
Goldsmith and his team used MapInfo Pro to generate 2D gridded map books of the venues and enriched it with points of interest (POI) data, such as foot bridges, cell masts, bus stops, and officer and partner locations. External datasets from other GIS units were also fed into the solution to seamlessly connect different formats for maximum context.
The 2D mapping created in MapInfo Pro proved to be the ideal foundation for the team to create cutting edge 3D visualizations. Leveraging capabilities provided by third-party providers, the team used aerial drone footage to build out an initial model. This was further augmented with 360-degree visualizations, using video footage that was meticulously captured by scanning over 140,000 square meters of the Summit venues.
The result was a hyper-accurate virtual representation, or digital twin, of the entire area. This enabled Devon and Cornwall Police and their partners, to anticipate security issues and create contingency plans using virtual reality headsets to remotely access locations during the planning phase. This removed the need to have more individuals on the ground than necessary in the run up to the event, while still enabling highly accurate contingency planning to take place.
“The data was accessible by our partners who could view our venues from any phone, tablet, or laptop, anywhere in the country,” said Goldsmith. “These insights benefitted a wide range of stakeholders such as our firearms, ops planning, and counter drone teams, and even external partners including the U.S. Secret Service, because they were able to understand the risks and opportunities different locations and routes presented.”
The G7 Summit went off without security hitch, with the GIS technology widely credited as being central to its success.
“Location intelligence is a crucial element of data integrity, allowing customers to unlock essential context from their data,” said Clarence Hempfield, Senior Vice President – Product Management at Precisely. “Working with Devon and Cornwall police allowed us to see our solutions in action, alongside third-party technology, to help enhance security at an internationally renowned event involving some of the world’s top leaders. We are incredibly proud to fuel organizations across the globe with the trusted data they need to confidently make critical decisions that better serve and protect their citizens.”
Learn more about how Devon and Cornwall Police used location intelligence for the G7 Summit planning here.
About Precisely
Precisely is the global leader in data integrity, providing accuracy, consistency, and context in data for 12,000 customers in more than 100 countries, including 99 of the Fortune 100. Precisely’s data integration, data quality, data governance, location intelligence, and data enrichment products power better business decisions to create better outcomes. Learn more at www.precisely.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221020006182/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom